A Review of Tertiary Referrals for Management of Pediatric Esophageal Eosinophilia

Frontiers in Pediatrics

Bridget Godwin¹ 

关键词: Eosinophilic esophagitis;    proton pump inhibitor-responsive esophageal eosinophilia;    guidelines;    proton pump inhibitor;    esophageal eosinophilia;   

DOI  :  10.3389/fped.2018.00173

学科分类：儿科学

来源: Frontiers

【 摘 要 】

Background: Eosinophilic esophagitis is a chronic, immune-mediated disease characterized by symptoms of esophageal dysfunction and ≥15 eosinophils/high-powered field (eos/hpf). Proton pump inhibitor responsive esophageal eosinophilia (1) is an entity of esophageal eosinophilia that responds to PPI therapy and is thought to be clinically and histologically similar to EoE. Current guidelines suggest therapy with PPI prior to endoscopy and use of PPI as first line for esophageal eosinophilia. In order to gain a better understanding of community practice patterns and to try differentiate between these two entities, we sought to evaluate the clinical presentations, treatment and final diagnoses of patients presenting to our institution for second opinions of esophageal eosinophilia.

【 授权许可】

CC BY